Jim Cramer: There's Good Risk and Bad Risk

Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.

2 Small-Cap Biotechs That Show Promise in 2021

ADMA Biologics and Organogenesis Holdings recently issued preliminary year-end 2020 results that were encouraging.

Walgreens Boots Alliance Rallies Ahead of Earnings

Has WBA rallied too much?

2 More Covered Call Opportunities That Are Calling Investors

Here are options plays involving promising small-caps Clearside Biomedical and Mustang Bio.

Trade Carefully With Soaring Gritstone Oncology

The history we are concerned about is the past couple of weeks.

UnitedHealth Group Charts Appear Toppy Ahead of Earnings

The technical indicators of the health benefits concern are not sending strong signals at present.

Moderna Now Looks Like an Effective Long Trade With Few Side Effects

MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.

Pacific Biosciences Reaches Our Price Target: Now What?

Let's check out the charts and technical indicators.

Emergent BioSolutions Is Looking Stronger

Here's an update on EBS shares.

Danaher Could Trade Higher

I do not find enough technical reasons to recommend new long positions at this point in time.